Distinct Patterns of Gene Expression Changes in the Colon and Striatum of Young Mice Overexpressing Alpha-Synuclein Support Parkinson's Disease as a Multi-System Process.
Parkinson’s disease
alpha-synuclein
brain-gut axis
gene expression profiling
Journal
Journal of Parkinson's disease
ISSN: 1877-718X
Titre abrégé: J Parkinsons Dis
Pays: Netherlands
ID NLM: 101567362
Informations de publication
Date de publication:
2023
2023
Historique:
medline:
7
11
2023
pubmed:
28
8
2023
entrez:
28
8
2023
Statut:
ppublish
Résumé
Evidence supports a role for the gut-brain axis in Parkinson's disease (PD). Mice overexpressing human wild type α- synuclein (Thy1-haSyn) exhibit slow colonic transit prior to motor deficits, mirroring prodromal constipation in PD. Identifying molecular changes in the gut could provide both biomarkers for early diagnosis and gut-targeted therapies to prevent progression. To identify early molecular changes in the gut-brain axis in Thy1-haSyn mice through gene expression profiling. Gene expression profiling was performed on gut (colon) and brain (striatal) tissue from Thy1-haSyn and wild-type (WT) mice aged 1 and 3 months using 3' RNA sequencing. Analysis included differential expression, gene set enrichment and weighted gene co-expression network analysis (WGCNA). At one month, differential expression (Thy1-haSyn vs. WT) of mitochondrial genes and pathways related to PD was discordant between gut and brain, with negative enrichment in brain (enriched in WT) but positive enrichment in gut. Linear regression of WGCNA modules showed partial independence of gut and brain gene expression changes. Thy1-haSyn-associated WGCNA modules in the gut were enriched for PD risk genes and PD-relevant pathways including inflammation, autophagy, and oxidative stress. Changes in gene expression were modest at 3 months. Overexpression of haSyn acutely disrupts gene expression in the colon. While changes in colon gene expression are highly related to known PD-relevant mechanisms, they are distinct from brain changes, and in some cases, opposite in direction. These findings are in line with the emerging view of PD as a multi-system disease.
Sections du résumé
BACKGROUND
BACKGROUND
Evidence supports a role for the gut-brain axis in Parkinson's disease (PD). Mice overexpressing human wild type α- synuclein (Thy1-haSyn) exhibit slow colonic transit prior to motor deficits, mirroring prodromal constipation in PD. Identifying molecular changes in the gut could provide both biomarkers for early diagnosis and gut-targeted therapies to prevent progression.
OBJECTIVE
OBJECTIVE
To identify early molecular changes in the gut-brain axis in Thy1-haSyn mice through gene expression profiling.
METHODS
METHODS
Gene expression profiling was performed on gut (colon) and brain (striatal) tissue from Thy1-haSyn and wild-type (WT) mice aged 1 and 3 months using 3' RNA sequencing. Analysis included differential expression, gene set enrichment and weighted gene co-expression network analysis (WGCNA).
RESULTS
RESULTS
At one month, differential expression (Thy1-haSyn vs. WT) of mitochondrial genes and pathways related to PD was discordant between gut and brain, with negative enrichment in brain (enriched in WT) but positive enrichment in gut. Linear regression of WGCNA modules showed partial independence of gut and brain gene expression changes. Thy1-haSyn-associated WGCNA modules in the gut were enriched for PD risk genes and PD-relevant pathways including inflammation, autophagy, and oxidative stress. Changes in gene expression were modest at 3 months.
CONCLUSIONS
CONCLUSIONS
Overexpression of haSyn acutely disrupts gene expression in the colon. While changes in colon gene expression are highly related to known PD-relevant mechanisms, they are distinct from brain changes, and in some cases, opposite in direction. These findings are in line with the emerging view of PD as a multi-system disease.
Identifiants
pubmed: 37638450
pii: JPD223568
doi: 10.3233/JPD-223568
pmc: PMC10657720
doi:
Substances chimiques
alpha-Synuclein
0
Snca protein, mouse
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1127-1147Références
Methods Mol Biol. 2017;1558:271-301
pubmed: 28150243
Cell. 2016 Dec 1;167(6):1469-1480.e12
pubmed: 27912057
Nat Commun. 2017 Jun 07;8:15500
pubmed: 28589937
Nat Commun. 2020 Sep 25;11(1):4873
pubmed: 32978376
BMC Syst Biol. 2012 Jun 12;6:63
pubmed: 22691535
Nat Rev Neurosci. 2017 Aug;18(8):509
pubmed: 28720825
J Neurochem. 2019 Mar;148(6):746-760
pubmed: 30589944
NPJ Parkinsons Dis. 2022 Nov 30;8(1):166
pubmed: 36450732
NPJ Parkinsons Dis. 2019 May 22;5:8
pubmed: 31123700
Brain. 2020 Oct 1;143(10):3077-3088
pubmed: 32830221
Neurotherapeutics. 2012 Apr;9(2):297-314
pubmed: 22350713
PLoS One. 2017 Oct 26;12(10):e0185056
pubmed: 29073143
Am J Physiol Gastrointest Liver Physiol. 2015 Jul 1;309(1):G1-9
pubmed: 25977509
J Neurochem. 2014 Sep;130(6):805-15
pubmed: 24749759
Bioinformatics. 2009 Apr 15;25(8):1091-3
pubmed: 19237447
Exp Neurol. 2012 Oct;237(2):318-34
pubmed: 22750327
Acta Neuropathol. 1990;79(6):581-3
pubmed: 1972853
J Parkinsons Dis. 2021;11(1):171-176
pubmed: 33337386
Neuroreport. 2008 May 28;19(8):873-6
pubmed: 18463504
Commun Biol. 2020 Sep 2;3(1):483
pubmed: 32879431
Proc Natl Acad Sci U S A. 2016 Sep 13;113(37):E5399-407
pubmed: 27573849
Antioxid Redox Signal. 2020 Jul 1;33(1):1-19
pubmed: 32103677
Database (Oxford). 2019 Jan 1;2019:
pubmed: 30951143
Front Neurosci. 2021 Jun 18;15:689723
pubmed: 34220443
Neurobiol Dis. 2020 Feb;135:104352
pubmed: 30579705
Sci Rep. 2016 Jun 28;6:28300
pubmed: 27350115
Genome Biol. 2014;15(12):550
pubmed: 25516281
Inflamm Bowel Dis. 2016 May;22(5):1049-55
pubmed: 26919462
J Cell Sci. 2019 May 2;132(9):
pubmed: 30910831
Bioinformatics. 2007 Jan 15;23(2):257-8
pubmed: 17098774
Nat Commun. 2020 Jul 23;11(1):3692
pubmed: 32703946
PLoS One. 2010 Nov 15;5(11):e13984
pubmed: 21085593
Neurobiol Dis. 2020 Feb;135:104426
pubmed: 30885792
Cell Res. 2020 Jan;30(1):70-87
pubmed: 31649329
Mov Disord. 2020 Jun;35(6):921-933
pubmed: 32092186
Parkinsonism Relat Disord. 2018 May;50:104-107
pubmed: 29454662
Neuron. 2019 Aug 21;103(4):627-641.e7
pubmed: 31255487
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Elife. 2020 Feb 11;9:
pubmed: 32043464
Sci Rep. 2018 Jun 25;8(1):9588
pubmed: 29942049
Nature. 2017 Mar 16;543(7645):424-427
pubmed: 28273069
Mol Neurodegener. 2018 May 11;13(1):21
pubmed: 29751824
Nat Genet. 2000 May;25(1):25-9
pubmed: 10802651
Mol Brain. 2009 Feb 09;2:5
pubmed: 19203374
Brain. 2021 Jul 28;144(6):1853-1868
pubmed: 33880502
JAMA Neurol. 2018 Aug 1;75(8):939-946
pubmed: 29710331
Clin Psychopharmacol Neurosci. 2018 Nov 30;16(4):422-433
pubmed: 30466215
Front Aging Neurosci. 2021 Apr 12;13:649627
pubmed: 33912026
Neurobiol Dis. 2013 Feb;50:42-8
pubmed: 23017648
J Mol Neurosci. 2012 Jan;46(1):109-21
pubmed: 21590270
Neurobiol Dis. 2018 Apr;112:106-118
pubmed: 29341898
Proc Natl Acad Sci U S A. 2015 Jul 28;112(30):9322-7
pubmed: 26170293
Nat Commun. 2016 Oct 27;7:13171
pubmed: 27786175
Nat Rev Gastroenterol Hepatol. 2020 Nov;17(11):673-685
pubmed: 32737460
Front Neurosci. 2019 Sep 27;13:992
pubmed: 31611762
Neurogastroenterol Motil. 2012 Sep;24(9):e425-36
pubmed: 22779732
Nat Rev Gastroenterol Hepatol. 2018 Aug;15(8):497-516
pubmed: 29844587
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Nucleic Acids Res. 2019 Jan 8;47(D1):D721-D728
pubmed: 30289549
Neuromolecular Med. 2019 Sep;21(3):239-249
pubmed: 31079293
J Neurosci. 2015 Mar 25;35(12):4942-52
pubmed: 25810524
Mol Neurodegener. 2021 Jun 2;16(1):34
pubmed: 34078425
Nat Genet. 2003 Jul;34(3):267-73
pubmed: 12808457
Gut. 2019 May;68(5):829-843
pubmed: 30554160
J Neurosci Res. 2002 Jun 1;68(5):568-78
pubmed: 12111846
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Sci Rep. 2020 Aug 4;10(1):13147
pubmed: 32753609
J Neurol. 2020 Aug;267(8):2207-2213
pubmed: 30989372
Nat Genet. 2010 Apr;42(4):332-7
pubmed: 20228799
Methods Enzymol. 2014;547:309-54
pubmed: 25416364
Inflamm Bowel Dis. 2019 Sep 18;25(10):e125-e126
pubmed: 31406986
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Mol Med Rep. 2015 Nov;12(5):7503-11
pubmed: 26458492
Physiol Res. 2019 Apr 30;68(2):295-303
pubmed: 30628835
Gut. 2020 Nov;69(11):1939-1951
pubmed: 32111634
Cell Signal. 2020 Jan;65:109442
pubmed: 31639492
Acta Neuropathol Commun. 2015 Mar 10;3:12
pubmed: 25775153
BMC Bioinformatics. 2008 Dec 29;9:559
pubmed: 19114008
Cell Rep. 2017 Sep 19;20(12):2846-2859
pubmed: 28930681
Neurobiol Aging. 2021 May;101:207-220
pubmed: 33639338
Front Aging Neurosci. 2022 Jul 28;14:909273
pubmed: 35966779
Mol Neurodegener. 2021 Feb 8;16(1):6
pubmed: 33557896
Sci Rep. 2016 Sep 14;6:33117
pubmed: 27624977
Neurobiol Dis. 2022 Feb;163:105599
pubmed: 34952161
Front Neurosci. 2019 Aug 07;13:839
pubmed: 31440136
Nat Genet. 2017 Feb;49(2):256-261
pubmed: 28067908
Nucleic Acids Res. 2000 Jan 1;28(1):27-30
pubmed: 10592173
Cell Rep. 2015 Oct 27;13(4):771-782
pubmed: 26489461
Inflamm Bowel Dis. 2012 Nov;18(11):2158-68
pubmed: 22374887
Nat Neurosci. 2020 Mar;23(3):327-336
pubmed: 32066981
J Parkinsons Dis. 2016 Oct 19;6(4):761-770
pubmed: 27589538
Mov Disord. 2014 Jul;29(8):999-1009
pubmed: 24898698
Nature. 2019 Jul;571(7766):565-569
pubmed: 31316206
PLoS One. 2011;6(12):e28032
pubmed: 22145021
J Alzheimers Dis. 2021;79(2):875-893
pubmed: 33361597
Neurobiol Dis. 2021 Dec;161:105557
pubmed: 34763110
Nat Rev Mol Cell Biol. 2014 Jan;15(1):19-33
pubmed: 24326621
J Parkinsons Dis. 2021;11(4):1677-1687
pubmed: 34334424
Cell Immunol. 2018 Aug;330:142-150
pubmed: 29291892